Efficacy of Preemptive Volume Loading to Prevent Arterial Hypotension During Induction of General Anesthesia (NICOM-MAP)

October 28, 2016 updated by: Hopital Foch
Induction of general anesthesia induces frequently arterial hypotension. The short term goal of this study is to evaluate if preemptive volume loading prevents such complication.

Study Overview

Status

Terminated

Conditions

Detailed Description

This is a randomized, prospective study which will include a total of 200 patients who are scheduled to undergo elective surgery. The research participants will be randomly assigned to

  • a control group that will receive a low preemptive volume loading (50 mL of gelatin),
  • a protocol group that will receive a high preemptive volume loading (500 mL of gelatin).

Volume loading is preceded by the measurement of stroke volume and cardiac output before and after a passive leg elevation test and followed by a standardized anesthetic protocol.

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Suresnes, France, 92151
        • Hopital Foch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients undergoing elective surgery.

Exclusion Criteria:

  • Difficult peripheral venous access
  • Allergy to gelatin
  • Symptomatic cardiac disease, rhythm trouble, pace-maker, aortic valvular disease, aortic disease
  • Morbid obesity, low BMI,
  • hypovolemia,
  • Raynaud syndrome or scleroderma,
  • Contra-indication to propofol, remifentanil or to the use of Bispectral Index,
  • Hematocrit < 20%.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High pre-emptive volume loading
intravenous administration
Active Comparator: Low pre-emptive volume loading
intravenous administration

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hypotension
Time Frame: 30 minutes
mean arterial pressure less than 70% of the baseline measurement
30 minutes

Secondary Outcome Measures

Outcome Measure
Time Frame
hemodynamic effect of leg passive elevation test
Time Frame: 30 minutes
30 minutes
hemodynamic effect of volume loading
Time Frame: 30 minutes
30 minutes
heart rate monitoring
Time Frame: 30 minutes
30 minutes
propofol dose when bispectral index is 50
Time Frame: 30 minutes
30 minutes
propofol site effect concentration when bispectral index is 50
Time Frame: 30 minutes
30 minutes
arterial pressure monitoring
Time Frame: 30 minutes
30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Morgan Le Guen, Hopital Foch
  • Study Director: Marc Fischler, Hopital Foch

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (Actual)

June 1, 2014

Study Completion (Actual)

June 1, 2014

Study Registration Dates

First Submitted

May 5, 2012

First Submitted That Met QC Criteria

May 5, 2012

First Posted (Estimate)

May 8, 2012

Study Record Updates

Last Update Posted (Estimate)

October 31, 2016

Last Update Submitted That Met QC Criteria

October 28, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2012/13
  • 2012-A00368-35 (Other Identifier: ANSM)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on Gelatin 500 mL

Subscribe